Eli Lilly & Company Foundation
North America, Indiana, United States, Indianapolis
Description
Eli Lilly & Company Foundation is an organization that supports programs designed to improve patient outcomes and enhance quality of life.
Investor Profile
Eli Lilly & Company Foundation has backed more than 24 startups, with 5 new investments in the last 12 months alone. The firm has led 4 rounds, about 17% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series A (42%)
- Series B (13%)
- Series C (13%)
- Seed (8%)
- Grant (8%)
- Series D (4%)
- Convertible Note (4%)
- Post Ipo Equity (4%)
- Series Unknown (4%)
Country Focus
- United States (92%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- The Netherlands (4%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Biopharma
- Pharmaceutical
- Life Science
- Manufacturing
- Bioinformatics
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
